Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Foundation Venture Capital Group, LLC, established in Princeton, New Jersey, focuses on supporting health-related startup companies through impact investing. The organization provides pre-seed and seed funding to innovative companies, assisting them in advancing towards commercialization. Their mission emphasizes fostering a culture of innovation and stimulating economic development by collaborating with local research institutions.
Currently, the firm manages a portfolio of 10 companies, primarily in the healthcare and biotech sectors. Foundation Venture Capital Group is committed to generating positive social impact through its investments, which include both monetary and nonmonetary support. The organization has established a reputation for its strategic partnerships with New Jersey-based research institutions, enhancing its ability to drive innovation in the health sector.
Foundation Venture Capital Group specializes in health-related technology and innovation, targeting startups in the pre-seed and seed stages. The firm provides both monetary and nonmonetary support, including strategic, operational, and back-office management assistance. Their investment strategy is designed to generate positive social impact while fostering economic development.
The organization actively seeks to collaborate with local research institutions to enhance its portfolio companies' growth potential. Foundation Venture Capital Group focuses on sectors such as healthcare and biotech, looking for innovative solutions that address pressing health challenges. They prioritize investments that demonstrate a clear path to commercialization and have the potential for significant social impact.
Foundation Venture Capital Group's portfolio includes a diverse range of companies focused on health-related technologies:
Roger S. Fine, Esq. - Chair. Roger has extensive experience in venture capital and law, providing strategic oversight for the firm.
Sandra Brown Sherman, Esq. - Secretary. Sandra brings legal expertise and governance experience to the organization.
Susan J. Flynn-Hollander, Esq. - Treasurer. Susan oversees financial management and reporting for the firm.
James Golubieski - President & CEO. James leads the organization, focusing on strategic growth and partnerships.
Laura Harrel - Vice President. Laura supports operational management and portfolio development.
Michael Wiley - Vice President. Michael is involved in investment strategy and portfolio management.
Aggie Worthington - Vice President & CFO. Aggie manages financial operations and investor relations.
Ana Katsafanas - Senior Venture Associate. Ana focuses on sourcing and evaluating new investment opportunities.
Jocelyn Mathew - Venture Associate. Jocelyn assists in portfolio management and due diligence.
Danielle Kozlosky - Venture Associate. Danielle supports investment analysis and operational initiatives.
Jeannine Hodkey - Program and Finance Admin. Jeannine manages administrative functions and program support.
To pitch Foundation Venture Capital Group, founders should email Jim Golubieski at jgolubieski@njhf.org. A comprehensive pitch deck is essential, including details about the business model, market opportunity, and team. The firm prefers to receive pitches via email and typically responds within a few weeks.
Warm introductions are beneficial but not mandatory. Founders should ensure their decks clearly articulate their value proposition and the potential social impact of their innovations.
Foundation Venture Capital Group has been actively supporting health-related startups, with notable recent activity including Kayothera's $8 million Series A funding for cancer therapeutics. The firm continues to provide ongoing support for companies like EValuate Diagnostics and Actinobac, which are developing innovative technologies in healthcare and biotech.
In addition to funding activities, the organization emphasizes collaboration with local research institutions to enhance the growth potential of its portfolio companies. This approach aligns with their mission of fostering innovation and economic development in the health sector.
What are Foundation Venture Capital Group's investment criteria?
The firm focuses on health-related technology and innovation, primarily targeting pre-seed and seed stage startups. They look for companies that demonstrate a clear path to commercialization and have the potential for significant social impact.
How can I apply or pitch to Foundation Venture Capital Group?
Founders can reach out via email to Jim Golubieski at jgolubieski@njhf.org. A detailed pitch deck outlining the business model, market opportunity, and team is recommended.
What makes Foundation Venture Capital Group different from other investors?
This firm emphasizes impact investing within the healthcare sector, providing both monetary and nonmonetary support, including strategic and operational assistance. Their collaboration with local research institutions enhances their portfolio companies' growth potential.
What is the geographic scope of Foundation Venture Capital Group's investments?
The organization primarily invests in startups located in North America, particularly those based in New Jersey.
What is the typical check size for investments?
Foundation Venture Capital Group typically invests in the pre-seed and seed stages, although specific check sizes are not disclosed. They focus on providing sufficient capital to help startups advance towards commercialization.
What kind of post-investment involvement does Foundation Venture Capital Group have?
The firm offers operational support and strategic guidance to its portfolio companies, helping them navigate the challenges of early-stage growth.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.